Clinical Trials

Hemorrhage, Colorectal Neoplasms

NCT06117891 2026-05-12

REFINE-IO

Active not recruiting

300 enrolled

Unresectable Hepatocellular Carcinoma

NCT04158258 2026-04-23

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Active not recruiting

2,907 enrolled

Breast

Breast Neoplasms

NCT02394834 2026-04-13

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

Active not recruiting

757 enrolled

Colorectal Neoplasms

NCT05839951 2025-11-12

STAR-T

818 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT05834348 2025-03-30

DELINOR

5,279 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT01775644 2021-12-02

An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)

3,003 enrolled

Colorectal Neoplasms

NCT02613208 2020-02-17

Argo

111 enrolled 14 charts

Breast

Breast Neoplasms

NCT02393898 2019-07-24

BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older

76 enrolled

Gynecologic

Ovarian Neoplasms

NCT02305615 2018-08-23

AVACONT

300 enrolled

Colorectal Neoplasms

NCT01712347 2018-07-31

An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer

351 enrolled

Colorectal Neoplasms

NCT01506167 2018-05-14

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)

719 enrolled

Colorectal Neoplasms

NCT02093000 2018-02-23

A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma

201 enrolled

Adenocarcinoma of Lung

NCT02831842 2018-01-26

A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status

4,278 enrolled

Colorectal Neoplasms

NCT03195569 2017-06-22

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

Unknown

15 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03170284 2017-05-31

AVALANCHE

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01343901 2017-04-25

PICASSO

210 enrolled 22 charts

Colorectal Neoplasms

NCT01399190 2016-09-28

An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

68 enrolled 8 charts

Colorectal Neoplasms

NCT02627144 2016-08-29

Bevacizumab in Metastatic Renal Cancer

365 enrolled 9 charts

Carcinoma, Renal Cell

NCT02596958 2016-04-04

Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants

996 enrolled 14 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT02612077 2016-03-11

CONCERT

765 enrolled 8 charts

Colorectal Neoplasms

NCT01215123 2016-02-22

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer

28 enrolled 7 charts

Breast

Breast Neoplasms

NCT01089413 2015-12-16

Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)

201 enrolled 11 charts

Colorectal Neoplasms

NCT01449825 2014-04-21

Hepatic Monitoring for Pazopanib

1 enrolled

Carcinoma, Renal Cell

NCT01381601 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

1 enrolled

Financial Stress, Carcinoma, Renal Cell

NCT01381614 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

1 enrolled